Stocks
Atara Biotherapeutics (ATRA) EBITDA margin US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -1 628% | -336.2% | -3 103% | -122.7% | ||||
| Changes by years, y/y, % | +1 292pp | -2 767pp | +38.1% | ||||||
Atara Biotherapeutics. EBITDA margin, %
Atara Biotherapeutics. EBITDA margin, changes, pp
Atara Biotherapeutics (ATRA) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA margin, % | ? | -3 142% | -1 365% | -106.7% | -57.5% | -48.6% | -122.7% | |
| Changes by years, y/y, % | -1 275pp | +32 815pp | +6 012pp | +7 103pp | +3 094pp | |||
| Changes by quarters, q/q, % | +4 018pp | +1 777pp | +1 259pp | +49pp | +9pp | |||
